Arkopharma Laboratories, aware of the environmental footprint related to its economic and industrial operations, has been taking action throughout the supply chain—from the procurement of raw materials to the distribution of products—to reduce pollution, protect resources and best manage greenhouse gas emissions.
Adapting to Climate Change
This determined, forward-looking process is not only the result of the historical commitment of Arkopharma Laboratories in favor of sustainable development.
It is because environmental performance is playing a growing role in the company's financial implications and is now recognized as something that cannot be separated from competitiveness.
The Group's environmental strategy is therefore based on two challenges: saving resources and limiting discharges (water, air and waste), from product design to end of life. This strategy is part of an overall health, safety and environmental management system. To define suitable environmental action plans, the Group uses assessment tools such as carbon accounting and energy audits.
What is Carbon Accounting?
The French Grenelle II law requires private companies with over 500 employees to assess the greenhouse gas emissions generated by their operations. This enables all companies to better understand the environmental impacts related to their operations and work to reduce them.
For Arkopharma, the objective is to assess the greenhouse gas emissions generated by our business and rank the weight of these emissions based on workstations. Further ways of saving energy were clarified during the updated 2014 carbon accounting.
Scope for work was defined in various areas of our business.
- Implementing an internal improvement and innovation approach;
- Planning for and managing energy consumption;
- Reducing emissions as much as possible;
- Guaranteeing compliance with legal obligations;
- Responding to the expectations of stakeholders, customers, shareholders, NGOs, etc.